MIRA Pharmaceuticals Inc. (MIRA)
MIRA Pharmaceuticals Statistics
Share Statistics
MIRA Pharmaceuticals has 16.56M shares outstanding. The number of shares has increased by 12.04% in one year.
| Shares Outstanding | 16.56M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 12.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 11.05M |
| Failed to Deliver (FTD) Shares | 6.36K |
| FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 1.26M, so 7.62% of the outstanding shares have been sold short.
| Short Interest | 1.26M |
| Short % of Shares Out | 7.62% |
| Short % of Float | 11.42% |
| Short Ratio (days to cover) | 0.47 |
Valuation Ratios
The PE ratio is -1.63 and the forward PE ratio is -3.27.
| PE Ratio | -1.63 |
| Forward PE | -3.27 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 4.46 |
| P/FCF Ratio | -4300.15 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MIRA Pharmaceuticals Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.7, with a Debt / Equity ratio of 0.
| Current Ratio | 8.7 |
| Quick Ratio | 8.7 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.12 |
| Cash Flow / Debt | -0.9 |
| Interest Coverage | -2.47 |
Financial Efficiency
Return on equity (ROE) is -2.74% and return on capital (ROIC) is -194.69%.
| Return on Equity (ROE) | -2.74% |
| Return on Assets (ROA) | -2.43% |
| Return on Capital (ROIC) | -194.69% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -5.99M |
| Employee Count | 2 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 6.73, so MIRA Pharmaceuticals 's price volatility has been higher than the market average.
| Beta | 6.73 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.25 |
| Relative Strength Index (RSI) | 43.36 |
| Average Volume (20 Days) | 1.37M |
Income Statement
| Revenue | n/a |
| Gross Profit | -8.53M |
| Operating Income | -8.53M |
| Net Income | -11.98M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.65 |
Balance Sheet
The company has 4.60M in cash and 5.06K in debt, giving a net cash position of 4.60M.
| Cash & Cash Equivalents | 4.60M |
| Total Debt | 5.06K |
| Net Cash | 4.60M |
| Retained Earnings | -21.29M |
| Total Assets | 4.27M |
| Working Capital | 3.54M |
Cash Flow
In the last 12 months, operating cash flow was -4.53K and capital expenditures -1, giving a free cash flow of -4.53K.
| Operating Cash Flow | -4.53K |
| Capital Expenditures | -1 |
| Free Cash Flow | -4.53K |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MIRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -58.56% |
| FCF Yield | -0.02% |
Analyst Forecast
The average price target for MIRA is $14, which is 1161.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $14 |
| Price Target Difference | 1161.3% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | 1.62 |
| Piotroski F-Score | 1 |